SamTrack (Update of the database of procedural processes related to medicinal products) (Q3068545): Difference between revisions
Jump to navigation
Jump to search
(Changed an Item: Edited by the beneficiary bot - attach the beneficiary based on the string) |
(Changed label, description and/or aliases in fr: translated_label) |
||
| label / fr | label / fr | ||
SamTrack (mise à jour de la base de données des procédures relatives aux médicaments) | |||
Revision as of 06:22, 26 November 2021
Project Q3068545 in Estonia
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | SamTrack (Update of the database of procedural processes related to medicinal products) |
Project Q3068545 in Estonia |
Statements
416,228.00 Euro
0 references
489,680.0 Euro
0 references
85.0 percent
0 references
1 April 2020
0 references
31 March 2022
0 references
Tervise ja Heaolu Infosüsteemide Keskus
0 references
59°25'28.09"N, 24°44'51.94"E
0 references
10134
0 references
Projekti tulemusena suudab Ravimiamet edastada Eesti arstidele, apteekritele ja patsientidele ravimite andmeid, mis tagavad ravimite ratsionaalse kasutamise, e-retsepti teenuste parema toimimise ja loob eeldused mitmete ravimite ohutuse ja kättesaadavusega seotud e-teenuste loomisele. Plaanitav lahendus suudab vahetada andmeid EE ja EL vastavate infosüsteemidega. Eesti ravimiturg muutub ettevõtetele atraktviisemaks, lihtsustub ravimite turule toomine ja s ellega paraneb ka ravimite kättesaadavus. (Estonian)
0 references
As a result of the project, the State Agency of Medicines will be able to provide Estonian doctors, pharmacists and patients with information on medicinal products, which will ensure rational use of medicines, better functioning of e-prescription services and create prerequisites for the creation of e-services related to the safety and availability of several medicines. The proposed solution will be able to exchange data with the respective information systems of EE and the EU. The Estonian pharmaceutical market is becoming more attractive for companies, making it easier to place medicines on the market, and the availability of medicines will also improve. (English)
16 August 2021
0 references
Identifiers
2014-2020.12.03.19-0548
0 references